Snapshot from Jul 25, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Regulatory / GeneDx Securities Class Action Lawsuit
Regulatory securities class action

GeneDx Securities Class Action Lawsuit

Analysis based on 7 articles · First reported Jul 20, 2026 · Last updated Jul 24, 2026

Sentiment
-40
Attention
3
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

GeneDx Holdings Corporation shares dropped 49.2% after the May 4 disclosure, significantly impacting shareholder value. The class action lawsuit may lead to financial penalties or settlements, further affecting the company's stock price and investor confidence.

Healthcare Biotechnology
Event Summary

Kahn Swick & Foti, LLC (KSF) reminds investors of the August 3, 2026 lead plaintiff deadline in a securities class action lawsuit against GeneDx Holdings Corporation Holdings Corp. (Nasdaq: WGS). The lawsuit, pending in the United States — United States District Court for the Northern District of California, alleges that GeneDx Holdings Corporation and certain executives failed to disclose material information during the Class Period (April 16, 2025 to May 4, 2026), violating federal securities laws. On May 4, 2026, GeneDx Holdings Corporation reported Q1 2026 financial results showing a drop in adjusted gross margin from 74% to 69%, missed revenue estimates for exome and genome lines, lowered full-year revenue guidance to $475-$490 million from $540-$550 million, and disclosed a $31.2 million impairment loss related to its prior acquisition of Fabric Genomics. Following this news, GeneDx Holdings Corporation shares fell 49.2% ($33.42 per share). The case is Basma v. GeneDx Holdings Corporation Holdings Corp., No. 26-cv-00880.

Key Actions
100 GeneDx Holdings Corporation misled investors
90 Kahn Swick & Foti reminded investors to file GeneDx Holdings Corporation
80 GeneDx Holdings Corporation disclosed impairment loss Fabric Genomics
Entities Involved
stock
GeneDx Holdings Corporation
GeneDx Holdings Corporation is the defendant in the securities class action lawsuit. The company's stock price fell 49.2% after disclosing poor Q1 2026 results and an impairment loss, leading to the lawsuit.
Importance 100.0 Sentiment -80.0
priv
Kahn Swick & Foti
Kahn Swick & Foti is the law firm representing the plaintiffs in the class action. The firm is seeking lead plaintiff applications and stands to gain from a potential settlement.
Importance 60.0 Sentiment 10.0
priv
Fabric Genomics
Fabric Genomics was acquired by GeneDx Holdings Corporation and later incurred a $31.2 million impairment loss, contributing to the financial decline that triggered the lawsuit.
Importance 40.0 Sentiment -30.0
govactor
United States — United States District Court for the Northern District of California
The court is presiding over the class action lawsuit. Its rulings will determine the outcome of the case.
Importance 30.0 Sentiment 0.0
per
Charles Foti
Charles Foti is a partner at Kahn Swick & Foti and former Attorney General of Louisiana. His involvement lends credibility to the lawsuit.
Importance 20.0 Sentiment 0.0
per
Lewis Kahn
Lewis Kahn is the managing partner at Kahn Swick & Foti and the primary contact for investors seeking to join the class action.
Importance 20.0 Sentiment 0.0
exch
Nasdaq
GeneDx Holdings Corporation is listed on Nasdaq under ticker WGS. The stock's decline and lawsuit may affect Nasdaq's reputation, but the exchange is not directly involved.
Importance 10.0 Sentiment 0.0
Relationships
GeneDx Holdings Corporation related ↔ Kahn Swick & Foti
GeneDx Holdings Corporation parent ↔ Fabric Genomics GeneDx Holdings Corporation is the corporate parent and sole owner of Fabric Genomics, having acquired the company in Ma
Kahn Swick & Foti related ↔ Fabric Genomics
Kahn Swick & Foti related ↔ United States — United States District Court for the Northern District of California
Kahn Swick & Foti related ↔ Charles Foti
Kahn Swick & Foti related ↔ Lewis Kahn
Fabric Genomics related ↔ United States — United States District Court for the Northern District of California
United States — United States District Court for the Northern District of California related ↔ Charles Foti
United States — United States District Court for the Northern District of California related ↔ Lewis Kahn
Charles Foti law partner ↔ Lewis Kahn Charles Foti serves as a partner under Managing Partner Lewis Kahn at the securities litigation firm Kahn Swick & Foti.
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.